Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Mild cognitive impairment

Topic: Amyloid, tau and blood-test diagnosis

We identified 8 brain structural features from 192 MRI features that were associated with the risk of MCI progressing to AD, including: left hippocampus, left inferior lateral ventricle, left amygdala, right middle temporal gyrus, left fusiform gyrus, right amygdala, left cortical total volume, and brain parenchyma total volume. In the multivariate joint model, the atrophy of left hippocampus volume (α = -0.0009, P = 0.0010), the expansion of left lateral inferior ventricle volume (α = 0.0003, P = 0.0238), the atrophy of right middle temporal gyrus volume (α = -0.0002, P = 0.0036), and the accelerated atrophy of brain parenchyma total volume (α = 0.000005, P = 0.0008) were all significantly associated with the risk of disease transformation. Additionally, the covariate APOE ε4 allele remained a significant independent risk factor (γ = 0.6930, P < 0.0001). Left hippocampal atrophy, left inferior lateral ventricular enlargement, right middle temporal gyrus atrophy, and brain parenchyma total volume atrophy were independently associated with the risk of progression from MCI to AD, alongside the established genetic risk factor APOE ε4.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Wang, Y., Song, W., Yang, X., Meng, W., Ma, Y., Wang, A., et al. (2026). A longitudinal analysis of T1-weighted MRI features associated with progression from mild cognitive impairment to Alzheimer’s disease. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02404-1

Vancouver

Wang Y, Song W, Yang X, Meng W, Ma Y, Wang A, et al. A longitudinal analysis of T1-weighted MRI features associated with progression from mild cognitive impairment to Alzheimer’s disease. BMC Medical Imaging. 2026. doi:10.1186/s12880-026-02404-1. PMID: 42115951.

BibTeX

@article{wang2026-42115951,
  author  = {Wang, Yanxia and Song, Wangchen and Yang, Xinyu and Meng, Weijing and Ma, Yonghua and Wang, Aimin and Guo, Guiya and Zhang, Zhaoxue and others},
  title   = {{A longitudinal analysis of T1-weighted MRI features associated with progression from mild cognitive impairment to Alzheimer’s disease}},
  journal = {BMC Medical Imaging},
  year    = {2026},
  doi     = {10.1186/s12880-026-02404-1},
  pmid    = {42115951},
  url     = {https://doi.org/10.1186/s12880-026-02404-1}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This longitudinal study identified several brain structural features and the APOE ε4 allele as independently associated with the risk of progression from mild cognitive impairment to Alzheimer's disease. It is about predicting progression and does not test any treatment, cure, or prevention.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 47 of the 97 points it could be judged on, which is 48 of 100. Total 48 of 100.47 of the 97 points we could judge = 48 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 47 of the 97 points we could judge it on, which is 48 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMC Medical Imaging)
Journal's citation record 0 / 4 BMC Medical Imaging: journal h-index 74 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 947 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Fuyan Shi: h-index 3 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42115951)
Free to read 2 / 2 Free to read
Points 47 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 47 of the 97 points we could judge it on is 48 out of 100.
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “machine”

834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →